Improving IBD in dogs through exercise by Dunning, Mark
Giving IBD the run around! 
 
Mark Dunning MA VetMB PhD CertSAM DipECVIM-CA 
School of Veterinary Medicine and Science, University of Nottingham, UK 
mark.dunning@nottingham.ac.uk 
 
 
Confirming (idiopathic) inflammatory bowel disease (IBD) in dogs can be difficult and 
continues to confound in achieving a definitive diagnosis in dogs presenting with chronic 
enteropathies (CE). It is recognised that intestinal inflammation can vary and may not correlate 
with disease activity and quality of life measures (Garcia-Sancho et al 2007, Procoli et al 2013, 
Walker et al 2013). These factors clearly contribute to the limitations in our understanding of 
canine CE which influences our therapeutic decision-making. One could therefore question 
the value of extensive investigations when the results of the tests do not invariably provide a 
definitive diagnosis. In dogs with severe protein-losing enteropathies, perhaps the rationale 
for such investigations may be much greater (Dandrieux 2016). Problems arise however in 
dogs that have less severe disease where the results of diagnostic investigations may be more 
equivocal. For example, the dog with a limited response to selected diet trials with low-grade 
lymphoplasmacytic inflammation on endoscopic biopsies. These dogs are all too common in 
practice and can lead to significant frustrations for vets and owners alike when managing 
them.  Recently, Dandrieux (2016) presented an eloquent review of what IBD really means in 
dogs. This emphasised the importance of a systematic diagnostic approach, particularly in 
attempting to identify both food and antibiotic responsive enteropathies. Whilst this presented 
a very clear path for investigations, in reality the availability of non-invasive diagnostic testing 
is very limited. For example, serological and faecal biomarkers which are used extensively in 
humans for the diagnosis and management of IBD (Lopez et al 2016, Kochhar and Lashner 
2017) are of limited availability in dogs and our ability to interpret any results is imperfect 
(Jergens et al 2010, Grellet et al 2014). In addition to these limitations, the diagnostic approach 
to and management of dogs suffering with CE also suffers from financial, clinical and ethical 
limitations. This can make for difficult decision-making. Therefore, making a ‘diagnosis’ by 
response to therapy is often necessitated, something specialists must accept, however 
dissatisfying. Given that this approach has clear limitations, the realities of managing these 
cases must also be appreciated. It is important that trial therapy, if it is introduced, has minimal 
side-effects which could lead to clinical deterioration or perhaps more worryingly to owners 
withdrawing treatment based on welfare grounds. In addition to the difficulties over diagnostic 
approaches and therapeutic decision-making in dogs with CE, clinical responses can also vary 
(Craven et al 2004, Allenspach et al 2007, Garcia-Sancho et al 2007). In this issue of the VR, 
Huang et al have undertaken a novel and very important study evaluating the role of exercise 
in managing dogs with CE. The dogs in this study were all suffering with CE and following the 
introduction of a structured exercise programme as part of their medical management plan, 
their respective disease activities were significantly improved compared with non-exercising 
controls after 10-weeks. This is an inspiring approach and provides an important starting point 
for understanding the role of novel adjunctive non-medical therapies for canine CE. There was 
no evidence in these dogs that the introduction of the exercise regime led to clinical 
deterioration. The results are compelling, leaving aside the limitations on case numbers, and 
elegantly introduce the concept that exercise can benefit dogs with CE. This study has great 
resonance for primary care practitioners given that not all dogs in the study had extensive 
investigations, including endoscopy to characterise their disease, yet demonstrated clinical 
benefit. Whilst novel in dogs, there is a significant amount of work on this area in humans with 
IBD. The studies to date would suggest a number of health benefits following the introduction 
of exercise whether this is structured or not. The benefits are seen in both immediate 
measures of disease activity and also in reducing the number of relapses and improving 
quality of life in individual patients (Packer et al 2010, Klare et al 2015, Shepherd 2016). Many 
of these benefits are understood to be directly on the immune system, which supports it’s 
value in dogs with CE (Nehlsen-Cannarella et al 1991, Mackinnon 1994, Lui et al 2015). The 
dogs in Huang’s study are described as sedentary and it is therefore difficult to know how 
exercise might improve disease activity in dogs with CE which are taking ‘normal’ amounts of 
exercise. However, in support of Huang’s findings, as little as 12 weeks of low-intensity 
exercise in humans with sedentary lifestyles can lead to improvements in both psychological 
and physiological wellbeing in patients with Crohn’s disease (Loudon et al 1999). What 
constitutes normal exercise however and the variable amount of exercise taken by humans 
suffering with IBD is a consideration when assessing any intervention (Rawsthorne et al 1999, 
Chan et al 2014, Tew et al 2016). A recent study indicated that whilst exercise has important 
positive effects in humans with IBD, a significant proportion of patients reported that their 
disease limited their ability to take ‘normal’ exercise (Tew et al 2016). It is unclear whether 
similar limitations to taking voluntary exercise exist in dogs suffering with CE and this is an 
important consideration. If we reflect on how regular exercise effects humans with IBD, given 
the majority of UK dogs will be taking regular exercise, some humans will derive benefit (Jones 
et al 2015) and some will suffer relapses (Chan et al 2014). It is therefore vital to ensure that 
any exercise programme introduced is appropriate – perhaps akin to baby bear’s porridge –  
being ‘just right’ is the ultimate goal. As discussed above (and highlighted by Dandrieux), the 
dissimilarities between human IBD and canine CE means that there are some difficulties in 
extrapolating either the benefits or complications of exercise in non-sedentary dogs with CE. 
Therefore, in order to answer this question, which may be more applicable to dogs with CE in 
the UK, Europe and the USA, further work is required using Huang et al’s study to form the 
basis of an exciting new area of investigation. I would therefore like to congratulate the authors 
in beginning to tackle this poorly explored area in dogs with CE and I very much look forward 
to seeing this study serve as an important starting point for future work. 
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